Completed
A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
NCT01377922
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +12 more
- Locations
-
- Birmingham, Alabama, United States
- Scottsdale, Arizona, United States
- Los Angeles, California, United States
- Palo Alto, California, United States